| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |